CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.82 -0.16 (-3.31%)
As of: Oct 21, 2026 · 12:16 PM EDT

CNS Pharmaceuticals (CNSP) Long-Term Debt Repayments (2019 - 2025)

Updated

CNS Pharmaceuticals (CNSP) recorded Long-Term Debt Repayments of $30,791 in Q4 2025, down 1.3% from $31,187 a year earlier and down 66.2% from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Long-Term Debt Repayments (2019 - 2025) Analysis & Trends

For FY2025, CNS Pharmaceuticals reported Long-Term Debt Repayments of $297,553, down 1.1% from FY2024.

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 47.2% (FY2020 to FY2025).
  • Across earlier years, Long-Term Debt Repayments came in at $300,806 in FY2024 (-31.4%), $438,733 in FY2023 (+2.6%), $427,700 in FY2022 (-10.4%) and $477,490 in FY2021.
  • The Q4 2025 figure is the lowest quarterly Long-Term Debt Repayments in data going back to Q1 2019.
  • On a year-over-year basis, Long-Term Debt Repayments has declined for nine consecutive quarters, with an average decline of 17.6% over the last eight quarters.
  • Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 92.3% in Q4 2021, against a decline of 55.9% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $90,974 (Q3 2025), $88,906 (Q2 2025) and $86,882 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 CNS Pharmaceuticals 2.14 Mn -40.10 Mn - 30,791.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 30,791.00
Sep 30, 2025 90,974.00
Jun 30, 2025 88,906.00
Mar 31, 2025 86,882.00
Dec 31, 2024 31,187.00
Sep 30, 2024 92,061.00
Jun 30, 2024 89,856.00
Mar 31, 2024 87,702.00
Dec 31, 2023 70,669.00
Sep 30, 2023 124,492.00
Jun 30, 2023 122,679.00
Mar 31, 2023 120,893.00
Dec 31, 2022 79,166.00
Sep 30, 2022 117,137.00
Jun 30, 2022 116,175.00
Mar 31, 2022 115,222.00
Dec 31, 2021 82,828.00
Sep 30, 2021 132,951.00
Jun 30, 2021 131,550.00
Mar 31, 2021 130,161.00
API Access

CNS Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CNSP&period=max&api_key=YOUR_API_KEY